Fortis Healthcare has unveiled the Fortis Institute of Genomic Medicine, a pioneering initiative aimed at advancing patient care through the integration of genomic science across India. Supported by Fortis’ extensive clinical ecosystem and the national reach of Agilus Diagnostics, the institute will bring together a multidisciplinary team of medical experts in areas such as molecular hematology, oncology, neurology, pediatrics, pathology, and genomic sciences, along with bioinformaticians and AI engineers.
Transforming Medicine with Genomics
Genomic science is reshaping the future of modern medicine, particularly in specialties like oncology, cardiology, and neurology. The institute’s work in onco-genomics will empower clinicians to decode the genetic drivers of cancer, enabling the use of targeted therapies that are more effective and less toxic than traditional treatments.
In the field of cardio-genomics, early detection of inherited cardiac conditions will become possible, which is crucial for families with a history of sudden cardiac arrest, unexplained heart failure, or congenital heart disease. In addition, neuro-genomics will provide new hope for patients suffering from complex neurological disorders. By leveraging gene-based insights, the institute will improve the diagnosis and personalized treatment of conditions such as epilepsy, Parkinson’s disease, and rare neurodevelopmental syndromes.
Future Initiatives: Health Registry and AI-Powered Genomic Reporting
Looking ahead, Fortis aims to launch a genomics-informed health registry and an AI-powered genomic reporting platform tailored specifically for Indian clinicians. The platform will adhere to international guidelines set by the American College of Medical Genetics and Genomics (ACMG), Association for Molecular Pathology (AMP), and the American Society of Clinical Oncology (ASCO). This tool will be compliant, clinically relevant, and intuitively designed for seamless integration into everyday medical practice, further advancing the application of genomics in healthcare.
Medical Experts Leading the Initiative
As reported by expresshealthcare, the launch event was graced by key medical experts from Fortis Memorial Research Institute (FMRI), including Dr. Rahul Bhargava, Principal Director and Chief of Bone Marrow Transplant; Dr. Vinayak Agarwal, Senior Director & Head of Non-Invasive Cardiology; Dr. Praveen Gupta, Principal Director and Chief of Neurology; Dr. Nitesh Rohatgi, Senior Director of Medical Oncology, FMRI, Gurugram; Dr. Ankur Bahl, Senior Director of Medical Oncology; Dr. Shrinidhi Nathany, Consultant in Molecular Hematology and Oncology; Yash Rawat, Facility Director; and Dr. Ritu Garg, Chief Marketing and Innovation Officer at Fortis Healthcare. These experts are leading the institute’s efforts to integrate genomic medicine into clinical practice and bring groundbreaking innovations to the field.
A New Era in Healthcare
With the establishment of the Fortis Institute of Genomic Medicine, Fortis Healthcare is positioning itself at the forefront of cutting-edge medical advancements. Through genomic medicine, the institute aims to transform treatment strategies, improve patient outcomes, and contribute to a healthier, more personalized future of healthcare across India.